Does TRANYLCYPROMINE Cause Intentional product use issue? 8 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Intentional product use issue have been filed in association with TRANYLCYPROMINE (Tranylcypromine). This represents 2.1% of all adverse event reports for TRANYLCYPROMINE.
8
Reports of Intentional product use issue with TRANYLCYPROMINE
2.1%
of all TRANYLCYPROMINE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Intentional product use issue From TRANYLCYPROMINE?
Of the 8 reports, 2 (25.0%) required hospitalization.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRANYLCYPROMINE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does TRANYLCYPROMINE Cause?
Hypertensive crisis (53)
Contraindicated product administered (50)
Drug interaction (44)
Depression (41)
Hypertension (39)
Headache (33)
Drug ineffective (30)
Insomnia (30)
Serotonin syndrome (30)
Dizziness (27)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which TRANYLCYPROMINE Alternatives Have Lower Intentional product use issue Risk?
TRANYLCYPROMINE vs TRASTUZUMAB
TRANYLCYPROMINE vs TRASTUZUMAB-ANNS
TRANYLCYPROMINE vs TRASTUZUMAB DERUXTECAN
TRANYLCYPROMINE vs TRASTUZUMAB-DKST
TRANYLCYPROMINE vs TRASTUZUMAB-DTTB